Johnson & Johnson's single-shot Covid-19 vaccine was recommended for authorization by an FDA panel. The agency is expected to clear it for broad use within days. https://t.co/AlTboTOSf6— The Wall Street Journal (@WSJ) February 26, 2021
Johnson & Johnson's single-shot Covid-19 vaccine was recommended for authorization by an FDA panel. The agency is expected to clear it for broad use within days. https://t.co/AlTboTOSf6